Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality
Open Access
- 1 December 2006
- journal article
- Published by Springer Science and Business Media LLC in Biological Procedures Online
- Vol. 8 (1), 55-62
- https://doi.org/10.1251/bpo118
Abstract
The application of naked DNA containing type I interferon (IFN) transgenes is a promising potential therapeutic approach for controlling chronic viral infections. Herein, we detail the application of this approach that has been extensively used to restrain ocular HSV-1 infection, for antagonizing vaginal HSV-2 infection. We show that application of IFN-α1, -α 5, and -β transgenes to vaginal mouse lumen 24 hours prior to HSV-2 infection reduces HSV-2 mediated mortality by 2.5 to 3-fold. However, other type I IFN transgenes (IFN- α 4, -α 5, -α 6, and -α 9) are non effectual against HSV-2. We further show that the efficacy of IFN-1 transgene treatment is independent of CD4+ T lymphocytes. However, in mice depleted of CD8+ T lymphocytes, the ability of IFN-α 1 transgene treatment to antagonize HSV-2 was lost.Keywords
This publication has 47 references indexed in Scilit:
- Current developments in viral DNA vaccines: shall they solve the unsolved?Reviews in Medical Virology, 2005
- RNA-Dependent Protein Kinase Is Required for Alpha-1 Interferon Transgene-Induced Resistance to Genital Herpes Simplex Virus Type 2Journal of Virology, 2005
- Genital Tract Shedding of Herpes Simplex Virus Type 2 in Women: Effects of Hormonal Contraception, Bacterial Vaginosis, and Vaginal Group B Streptococcus ColonizationClinical Infectious Diseases, 2005
- Antibody targeted gene transfer to endotheliumThe Journal of Gene Medicine, 2002
- Stromal Keratitis and Anterior Uveitis Due to Herpes Simplex Virus-2 in a Young ChildJapanese Journal of Ophthalmology, 2001
- The Expanding Spectrum of Herpesvirus Infections of the Nervous SystemBrain Pathology, 2001
- Therapeutic efficacy of DNA encoding IFN-a1 against corneal HSV-1 infectionCurrent Eye Research, 2000
- Targeted Delivery of Plasmid DNA to Myogenic Cells via Transferrin-Conjugated Peptide Nucleic AcidMolecular Therapy, 2000
- Prospects for Control of Herpes Simplex Virus Disease through ImmunizationClinical Infectious Diseases, 2000
- Cervical Shedding of Herpes Simplex Virus in Human Immunodeficiency Virus–Infected Women: Effects of Hormonal Contraception, Pregnancy, and Vitamin A DeficiencyThe Journal of Infectious Diseases, 2000